The most recent trading session ended with Gilead Sciences (GILD) standing at $91.41, reflecting a -0.51% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500 ...

Gilead Sciences Inc (GILD) stock saw a decline, ending the day at $92.01 which represents a decrease of $-2.10 or -2.23% from the prior close of $94.11. The stock opened at $93.93 and touched a low of ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Check the time stamp on this data. Updated AI-Generated Signals for Gilead Sciences Inc. (GILD) available here: GILD.

Gilead Sciences Inc (GILD) stock saw a modest uptick, ending the day at $92.37 which represents a slight increase of $0.36 or 0.39% from the prior close of $92.01. The stock opened at $92.59 and ...

智通财经APP获悉，1月2日，NMPA官网显示，吉利德(GILD.US)的HIV疗法来那帕韦钠片及来那帕韦钠注射液（Lenacapavir）的上市申请已获批准。那帕韦钠是一款first-in-class长效HIV衣壳抑制剂，可通过干扰病毒生命周期的多 ...

Nvidia has dominated the AI narrative in the stock market, captivating investors and the media after soaring 2,190% over the ...

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the target of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 21,980,000 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences (GILD) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...

周二，法国兴业银行集团旗下的伯恩斯坦维持了对吉利德科学公司 (NASDAQ:GILD)的"跑赢大市"评级和105.00美元的目标价。该公司目前交易价格为92.05美元，接近其52周高 ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively ...